ALX Oncology Holdings Inc.
NASDAQ:ALXO
0.5303 (USD) • At close April 28, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|
| Assets: | |||||||
| Current Assets: | |||||||
| Cash & Cash Equivalents
| 17.567 | 22.406 | 282.906 | 363.667 | 434.219 | 9.017 | 8.262 |
| Short Term Investments
| 110.19 | 160.33 | 217.385 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 127.757 | 182.736 | 282.906 | 363.667 | 434.219 | 9.017 | 8.262 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0.536 | 0.932 |
| Inventory
| 0 | 0 | -17.699 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 6.595 | 5.923 | 4.762 | 6.704 | 3.546 | 0.256 | 1.014 |
| Total Current Assets
| 134.352 | 188.659 | 270.969 | 367.019 | 434.219 | 9.809 | 10.208 |
| Non-Current Assets: | |||||||
| Property, Plant & Equipment, Net
| 2.905 | 10.841 | 9.813 | 3.472 | 0.052 | 0.86 | 0.956 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 3.524 | 35.411 | 16.699 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 6.994 | 7.642 | 9.008 | 9.692 | 1.783 | 0.007 | 0 |
| Total Non-Current Assets
| 13.423 | 53.894 | 35.52 | 13.164 | 1.835 | 0.867 | 0.956 |
| Total Assets
| 147.775 | 242.553 | 306.489 | 380.183 | 436.054 | 10.676 | 11.164 |
| Liabilities & Equity: | |||||||
| Current Liabilities: | |||||||
| Account Payables
| 4.497 | 8.591 | 8.073 | 3.764 | 0.004 | 3.748 | 0.697 |
| Short Term Debt
| 0.435 | 1.575 | 1.041 | 0.742 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0.179 | 0.001 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 10.532 | 0 | 0 | 0 |
| Other Current Liabilities
| 13.568 | 25.835 | 19.211 | 10.789 | 6.021 | 1.235 | 1.176 |
| Total Current Liabilities
| 18.5 | 36.001 | 28.325 | 15.295 | 6.204 | 4.984 | 1.873 |
| Non-Current Liabilities: | |||||||
| Long Term Debt
| 0 | 15.622 | 9.389 | 0 | 0 | 5.421 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0.135 | 0.136 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 15.657 | 1.218 | 5.311 | 1.839 | 0.005 | 0.547 | 0 |
| Total Non-Current Liabilities
| 15.657 | 16.84 | 14.7 | 1.839 | 0.005 | 5.968 | 0.136 |
| Total Liabilities
| 34.157 | 52.841 | 43.025 | 17.134 | 436.054 | 10.952 | 2.009 |
| Equity: | |||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 436.054 | 70.363 | 60.933 |
| Common Stock
| 0.053 | 0.05 | 0.041 | 0.041 | 0.04 | 0.003 | 0.003 |
| Retained Earnings
| -621.122 | -486.272 | -325.467 | -201.985 | -118.522 | -72.782 | -53.539 |
| Accumulated Other Comprehensive Income/Loss
| 0.275 | 0.256 | -0.845 | -0 | -554.616 | 0 | -1.02 |
| Other Total Stockholders Equity
| 734.412 | 675.678 | 589.735 | 564.993 | 548.327 | 2.14 | 2.778 |
| Total Shareholders Equity
| 113.618 | 189.712 | -325.467 | -201.985 | -118.522 | -0.276 | 9.155 |
| Total Equity
| 113.618 | 189.712 | -325.467 | -201.985 | -118.522 | -0.276 | 9.155 |
| Total Liabilities & Shareholders Equity
| 147.775 | 242.553 | -282.442 | -184.851 | 436.054 | 10.676 | 11.164 |